United Kingdom (UK)
Recombinant monoclonal antibody to Canarypox Virus. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma CNPV-5A11.
Alternative Name(s) of Target: Canarypox virus KP1; CNPV KP1; Anti-CNPV 5A11/17D7; CNPV 5A11/17D7; CNPV-5A11 04.11.20
Immunogen: The original mouse IgG2a version of this antibody was raised against sucrose-gradient purified canarypox virus (CNPV) KP1.
Specificity: This antibody recognizes CNPV or pigeonpox virus. It doesn not cross-react with the fowlpox virus. Canarypox virus (CNPV) is an Avipoxvirus and etiologic agent of canarypox, a disease of wild and captive birds that can cause significant losses. CNPV is considered a disease of songbirds for example, canaries, magpies and nightingales and is associated with higher mortality rates when compared to other avian pox viruses. The general symptoms of CNPV are similar to other species of avian pox viruses and are characterized by pustules and diphtheria or pneumonia like symptoms.
Application Notes: This antibody is recommended for the detection and analysis of the canarypox virus. It can be used for the development of the diagnostic tests for canarypox infection. This clone (5A11/17D7) was successfully used to detect the canarypox viruses via ELISA in an avipoxvirus-differentiation assay (Krone et al., 2004; pmid: 14765897).
Antibody first published in:
Burck et al. Antigenic and genetic differentiation of avian poxviruses (Antigene und genetische Differenzierung von Avipockenviren) Vet. Med. Diss. 1-168, Munich. PMID:
Note on publication:
Describes the characterization of this antobody.